Diabetes treatment devices market seen reaching $16.53 billion by 2030

The diabetes treatment devices market is projected to grow from $12.34 billion in 2025 to $13.11 billion in 2026, with North America leading and Asia-Pacific expected to grow fastest. The report points to rising obesity, smart insulin tools, and remote monitoring as key drivers shaping demand through 2030.

Why it matters: - The diabetes treatment devices market is expanding as diabetes cases rise worldwide and patients adopt more connected tools for blood sugar management. - Growth in the market ties directly to obesity trends, which increase diabetes risk and drive demand for monitoring and insulin-delivery devices. - The shift toward homecare, remote monitoring, and smartphone-connected devices could change how patients manage diabetes outside clinical settings.

What happened: - The Business Research Company released a report on the global diabetes treatment devices market on Aug. 4, 2026. - The market is projected to grow from $12.34 billion in 2025 to $13.11 billion in 2026, a CAGR of 6.2%. - The market is forecast to reach $16.53 billion by 2030, at a CAGR of 6.0%. - Download a free sample of the report. - View the full report.

The details: - Diabetes treatment devices include tools for glucose monitoring, insulin delivery, and other diabetes-related health needs. - The devices are used to help maintain blood glucose control and reduce diabetes complications. - Historical growth came from reliance on traditional blood glucose meters, limited awareness of self-monitoring devices, expanding hospital and diagnostic center infrastructure, rising diabetes prevalence, and steady use of standard lancets and testing strips. - Future growth is expected to be supported by smart insulin pens and pumps, real-time continuous glucose monitoring, smartphone and wearable integration, remote patient monitoring programs, and growth in diabetes clinics and online distribution channels. - Expected product trends include wider adoption of continuous glucose monitoring devices, smart insulin delivery systems, homecare and remote monitoring, wearable and handheld glucometers, and safety-enhanced lancets and testing strips. - Rising obesity is one of the main growth drivers for the market. - In September 2024, the CDC reported that adult obesity rates in 2023 reached 35% or higher in 23 U.S. states, up from 22 states in 2022.

Between the lines: - The report suggests diabetes care is moving from basic testing toward more automated, connected, and patient-managed devices. - North America held the largest market share in 2025, while Asia-Pacific is expected to post the fastest growth during the forecast period. - The regional outlook points to broad demand across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

What's next: - Adoption of continuous glucose monitoring and smart insulin systems is expected to accelerate through 2030. - Remote monitoring and online distribution channels are likely to become more important as home-based care expands. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The Business Research Company also lists expert contact details for follow-up on the report.